Business Context and Reporting Period
Company: II-VI Incorporated (filing as COHERENT CORP. in metadata, but text confirms II-VI)
Reporting Period: Fiscal year ended June 30, 1996
Business Overview: II-VI designs, manufactures, and markets optical and electro-optical components, devices, and materials for precision use in infrared, near-infrared, visible-light, and x-ray/gamma-ray instruments. The company operates as a single segment focused on the laser processing industry, with significant exposure to industrial, scientific, medical, and military markets. Key products include Zinc Selenide optics for CO2 lasers, YAG laser components, and Cadmium Zinc Telluride substrates for nuclear radiation detection.
Key Financial Metrics
Note: Specific revenue, profit, cash flow, and margin figures are incorporated by reference to the 1996 Annual Report to Shareholders and are not explicitly detailed in the provided text.
- Order Backlog: $12.9 million as of June 30, 1996 (up from $6.9 million in 1995).
- Research & Development (R&D) Expenditures: Approximately $1.7 million for fiscal 1996 (Company-funded and contract research combined).
- Contract Research Revenues: Approximately $1.7 million for fiscal 1996.
- International Sales: Accounted for approximately 43% to 47% of revenues over the last three fiscal years.
- Market Capitalization: Approximately $88.6 million (as of September 10, 1996).
- Outstanding Shares: 6,331,738 shares of Common Stock (as of September 10, 1996).
- Stock Price: Last reported sale price of $19.125 per share (September 10, 1996).
- Debt and Liquidity: Specific debt and liquidity figures are not provided in the text; financial statements are incorporated by reference.
Material Changes vs. Prior Period
- Order Backlog Growth: Backlog increased 87% year-over-year to $12.9 million.
- Backlog Composition: Manufacturing orders now comprise 82% of the backlog (down from 96% in 1995), while contract research and development backlog increased due to a $2.3 million, two-year DARPA contract award.
- Acquisitions: Completed the merger with Lightning Optical Corporation in February 1996.
- Stock Performance: Significant volatility observed; Fiscal 1996 stock price ranged from a low of $9.25 to a high of $23.00, compared to a range of $1.81 to $13.88 in Fiscal 1995.
Guidance, Outlook, and Risks
Outlook and Strategy: The company anticipates continued growth driven by the proliferation of industrial laser applications and the expansion of its aftermarket business. Strategic initiatives include expanding manufacturing capacity in Florida, starting operations in China in fiscal 1997, and pursuing acquisitions to expand product lines. Management expects R&D spending to remain between 5% and 8% of product sales.
Key Risks and Contingencies:
- Supply Chain Dependence: Critical reliance on Zinc Selenide and Hydrogen Selenide. Zinc Selenide has only one outside merchant source, and Hydrogen Selenide is produced internally but has only one outside supplier if internal production fails.
- Manufacturing Yields: Fluctuations in manufacturing yields for complex materials like Zinc Selenide could materially affect results.
- Environmental and Safety: Use of hazardous materials (Hydrogen Selenide) and low-level radioactive materials (Thorium Fluoride). The company does not carry environmental impairment insurance.
- International Operations: Exposure to currency fluctuations, tariffs, and political instability, particularly in Japan and the UK where sales are denominated in foreign currencies.
- Intellectual Property: Reliance on trade secrets rather than patents; risk of third-party infringement claims or inability to license necessary technology.
- Growth Management: Higher fixed cost structure requires increased revenue to maintain historical margins.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures in the 1996 Annual Report to Shareholders (incorporated by reference).
- Confirm the status and integration progress of the Lightning Optical acquisition.
- Assess the company's ability to maintain manufacturing yields for Zinc Selenide given the single-source supply risk.
- Review the details of the $2.3 million DARPA contract and its impact on future R&D revenue.
- Monitor currency exchange rates for the Japanese Yen and British Pound, as sales in these regions are not denominated in USD.
- Check for any updates on the planned manufacturing facility construction in Florida and the China operations start-up.